Company Filing History:
4 out of 29 
2 out of 2 Years Active: 2006-2012
Title: Richard H. Roberts: Innovator in Metaxalone Therapeutics
Introduction
Richard H. Roberts is an esteemed inventor located in Lakewood, NJ, recognized for his significant contributions to the pharmaceutical industry. With a collection of six patents under his name, Roberts has dedicated his career to advancing methods and applications surrounding metaxalone, a muscle relaxant.
Latest Patents
Among his latest patents, Roberts has focused on the methods of using metaxalone products. One embodiment of his patent details a method that determines if a patient requiring metaxalone therapy is on a substance that acts as an inhibitor or inducer of cytochrome P450 isozymes. This includes specific enzymes such as CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. By adjusting the administration of metaxalone accordingly, adverse events can be avoided. His innovation also includes a method that informs users about the metabolism of metaxalone by these cytochrome P450 isozymes. Furthermore, Roberts has developed pharmaceutical safety dosage forms that combine a pharmaceutical with an antagonist, ensuring safety if the dosage form is disrupted.
Career Highlights
Roberts has had a fruitful career, having worked with notable companies such as Mutual Pharmaceutical Company, Inc., and Mutual Pharmaceuticals, Inc. His work has focused on pharmaceutical formulations that enhance patient safety and efficacy in drug administration.
Collaborations
Throughout his career, Roberts has collaborated with talented individuals such as Jie Du and Matthew William Davis. These partnerships have likely contributed to the successful development and refinement of his innovative solutions in pharmaceutical applications.
Conclusion
Richard H. Roberts stands out as a pivotal figure in the realm of pharmaceutical inventions, particularly related to metaxalone. His ongoing commitment to improving methods of drug administration demonstrates a profound understanding and dedication to patient safety and effective therapeutic solutions.